The table below shows Nuvation Bio Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
$5.07M
-$42.63M
-$15.70M
-$19.33M
-$24.93M
-$14.73M
Capital expenditure
-
-
-
-
-
-
Investing cash flow
-$43.64M
$54.18M
$7.54M
-$52.00M
-$5.55M
-$1.08M
Dividends paid
-
-
-
-
NUVB operating cash flow (10-K history)
Nuvation Bio Inc. reported operating cash flow of -$173.43M for fiscal year 2025. That is down 33.0% from -$130.41M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow declined from -$36.53M (FY 2020) to -$173.43M. Figures come from the company's audited annual reports as filed with the SEC.